Microsoft PowerPoint - lokhorst Kos.ppt [Read-Only] [Compatibility Mode] - Cell Host - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2012-04-18 11:55:00 Transplantation medicine Hematology Hematopoietic stem cell transplantation Lymphatic system Surgical oncology Graft-versus-host disease End point of clinical trials Progression-free survival Interferon Medicine Biology Health		Microsoft PowerPoint - lokhorst Kos.ppt [Read-Only] [Compatibility Mode] Add to Reading List Source URL: myeloma.org Download Document from Source Website File Size: 202,47 KB Share Document on Facebook

	UNIVERSITÄTSKLINIKUM Schleswig-Holstein Immuntherapie des Glioblastoms Sampson et al. - Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor DocID: 1rgeq - View Document
	Guideline on CT in Small Populations - Adopted DocID: 1qPMu - View Document
	MayImproving Trial Success by Improving Tumor Assessment Jamal Gasmi, MD, PhD l Vice President & Global Leader Oncology & Hematology Drug Development, ICON Clinical Research James Conklin, MD, MS l Senior Vice Pre DocID: 1pCHm - View Document
	Updated Results of Phase 1b of Tarextumab (TRXT, OMP-59R5, anti-Notch 2/3) in Combination with Etoposide and Platinum Therapy (EP) in Patients (pts) with Untreated Extensive-Stage Small Cell Lung Cancer (ED-SCLC) Copies DocID: 1oRDd - View Document
	Encouraging progression free survival results in subjects with newly diagnosed advanced stage renal cell carcinoma (RCC) participating in a phase II study testing the safety and activity of a dendritic cell-based immunot DocID: 1mrph - View Document